March 2022 - Page 5 of 7 - CannabisNewsWire

FridayMar 11, 2022 4:20 pm

420 with CNW — A Glimpse at the Road Ahead Before Marijuana Beverages Dominate the Market

Released estimates show that by the end of this year, the THC-infused beverages market will be valued at $340 million. Manufacturers of marijuana beverages need to understand the gaps in the market and find ways to bridge those gaps in order to approach the same levels of market share as its alcohol counterpart. Consumer sentiment is the primary driver in the creation of new categories, and there are four areas of opportunity driven by consumer sentiment, which manufacturers in the flourishing cannabis beverage industry should consider. Those areas include the following: Individuals who are sensitive to the effects of alcoholic…

FridayMar 11, 2022 4:25 am

420 with CNW — Data Shows More Banks Are Working with Cannabis Businesses as Clients

Data recently released by the Financial Crimes Enforcement Network shows that the number of financial institutions working with cannabis businesses grew in 2021. While it isn’t clear if this increase is associated with moves in Congress to approve a marijuana banking reform measure, this federal data shows that banks feel more comfortable serving cannabis businesses located in state-legal markets. As of September 2021, there were 755 credit unions and banks that revealed that they were actively servicing marijuana clients. This is a slight increase from the figure recorded in the previous quarter. Despite the presence of the Financial Crimes Enforcement…

ThursdayMar 10, 2022 4:20 pm

420 with CNW — Poll Reveals More Americans Prefer Marijuana Consumption to Alcohol

According to a YouGov survey, many Americans prefer that people switch their consumption preference from alcohol to marijuana. The survey was conducted in February 20200, and it relied on responses from 10,412 Americans. According to the poll, 27% of the respondents agreed with the idea of people substituting marijuana for alcohol while 20% disagreed. Meanwhile, the majority — some 38% — replied that it was neither good nor bad while the remaining 15% were unsure. Several studies have been done in the past to compare the pros and cons of marijuana to those of alcohol. Proponents have indicated the long-term…

ThursdayMar 10, 2022 11:30 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Builds Quality, Consistency in Florida, Michigan Operations

Red White & Bloom Brands is a cannabis and hemp multi-state operator, focused on product consistency and quality, critical to the developing cannabis market that is rapidly growing state by state The company’s successes in Michigan, a leading U.S. cannabis market, include the acquisition of full licensing, a 15,000-square-foot manufacturing and distribution facility, and more than 20 new potential locations for cultivation and dispensaries In Florida, RWB is building on its acquisition of a 45,000-square-foot cultivation facility to provide premium inventory to several existing dispensaries and new sites expected to open during this year’s Q1 Mainstream wellness consumers have cast…

ThursdayMar 10, 2022 11:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX), a Global Innovator in Drug Delivery Platforms

Lexaria’s patented DehydraTECH technology proved effective for sildenafil delivery in animal study PDE5-A21-1 The company also made some notable strides with its HYPER-H21-4 clinical study on hypertension and heart disease treatment using DehydraTECH-CBD By doing so, it hopes to capitalize on the growing cardiovascular drugs market, which is projected to be valued at $107.8 billion by 2025 (https://cnw.fm/8bk1Y) With the success of its studies thus far, the company seeks to conduct even more trials over the 2022 calendar year Lexaria Bioscience (NASDAQ: LEXX) has, since its inception, remained committed to enhancing the speed and efficiency of orally-delivered fat-soluble active molecules…

ThursdayMar 10, 2022 4:20 am

420 with CNW — Unions, Businesses and Groups Spend Millions Lobbying for Federal Cannabis Reforms

As more states in the U.S. legalize marijuana for medical or recreational use and the industry grows, political not-for-profit organizations, trade associations and cannabis businesses continue to lobby for cannabis reform and legalization. Lobbyists are being paid a lot to weigh in on the cannabis reform measures being introduced in Congress, with OpenSecrets finding that 22 clients spent roughly $4.3 million last year to employ professional lobbyists to keep tabs on cannabis reform. OpenSecrets, which is a not-for-profit research group tracking political spending, found that this figure had increased from the $3.6 million recorded in 2020, noting that in the…

WednesdayMar 09, 2022 4:20 pm

420 with CNW — Delayed Review Leaves Canada’s Cannabis Industry in Suspense

A review of Canadian legislation that seeks to address key issues in the country’s cannabis industry has been delayed. The Cannabis Act is in need of a mandatory review that was scheduled for October 2021, three years after Canada made it legal to use marijuana for recreational purposes. According to Tammy Jarbeau, a health spokesperson, a legislative review is currently in the works. Once the review launches, the industry seeks to address issues, some of which are not covered in the Cannabis Act. Some of those issues include excise taxes, potency limits of products, and the marketing and advertising of…

WednesdayMar 09, 2022 9:30 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Updates Recent Product Diversification Efforts and Strategic Acquisitions Developments; Announces VP Of Sales & Marketing Appointment

In a recent update, InMed Pharmaceuticals president and CEO, Eric A. Adams, lauded the company’s progress and achievements so far, particularly with its product diversification and strategic acquisitions Adams noted the company’s commitment to launching more products and executing more programs to continue growing its product portfolio InMed also announced the appointment of Gerald (“Jerry”) P. Griffin III as Vice President of Sales and Marketing at BayMedica, its wholly-owned subsidiary In a conference call and webcast on February 15, 2022, Eric A. Adams, President and Chief Executive Officer of InMed Pharmaceuticals (NASDAQ: INM), emphasized the company’s successful product diversification and…

WednesdayMar 09, 2022 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Strengthens Foothold in U.S. Wellness Market with Acquisition of JustCBD, Appoints Jessie Casner as CMO

Flora Growth owns and operates a portfolio of brands offering wholesale products, consumer packaged goods, or pharmaceutical and medical products The three-pronged operational approach has allowed the company to substantially expand and accelerate its revenue growth over the short term Recently, Flora Growth added yet another brand, JustCBD, to its portfolio; JustCBD’s performance is expected to immediately contribute to FLGC’s 2022 revenues and earnings Flora Growth also appointed Jessie Casner as the Chief Marketing Officer; Ms. Casner will lead communications, narrative building, and consumer marketing strategies, in addition to crafting brand awareness activities Founded on the premise of becoming a…

WednesdayMar 09, 2022 4:25 am

420 with CNW — Online Article on Former President Clinton’s Favorable Comments on CBD Deleted

Cannabis is one of the most polarizing topics in America. While some wrongly believe that the controversial drug inevitably leads to addiction and criminal activity, others are appalled that millions of Americans have had their lives disrupted by what they see as draconian prohibition rules targeting a benign substance. With the White House, Senate and Congress in the hands of the Democrats, marijuana policy has become even more of a hot topic. A now-deleted news report from Cannabis & Tech Today stated that even former president Bill Clinton had heard about CBD’s potential as an alternative medicine. The article was…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Month: March 2022